{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:28:08Z","timestamp":1793968088864,"version":"4.8.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ejmech.2026.119398","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:47:22Z","timestamp":1791503242000},"page":"119398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Antimalarial efficacy of isatin and oxindole derivatives: A comprehensive update"],"prefix":"10.1016","volume":"321","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3432-7108","authenticated-orcid":false,"given":"Ravi Kumar","family":"Thakur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5295-4880","authenticated-orcid":false,"given":"Om P.S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119398_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/pathogens15020137","article-title":"The evolving landscape of malaria prevention strategies: a review of recent developments","volume":"15","author":"Charavanamuttu","year":"2026","journal-title":"Pathogens"},{"key":"10.1016\/j.ejmech.2026.119398_bib2","series-title":"Addressing the Threat of Antimalarial Drug Resistance","year":"2025"},{"key":"10.1016\/j.ejmech.2026.119398_bib3","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm.4381","article-title":"Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic","volume":"23","author":"Blasco","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119398_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pt.2015.11.010","article-title":"Insecticide resistance in African anopheles mosquitoes: a worsening situation that needs urgent action to maintain malaria control","volume":"32","author":"Ranson","year":"2016","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2026.119398_bib5","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/S2214-109X(25)00415-2","article-title":"Effectiveness of the RTS,S\/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi","volume":"14","author":"Ndeketa","year":"2026","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.ejmech.2026.119398_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41541-017-0035-3","article-title":"Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium","volume":"2","author":"Coelho","year":"2017","journal-title":"npj Vaccines"},{"key":"10.1016\/j.ejmech.2026.119398_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113084","article-title":"Antimalarial application of quinones: a recent update","volume":"210","author":"Patel","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s11427-015-4948-7","article-title":"The discovery of artemisinin and the nobel prize in physiology or medicine","volume":"58","author":"Su","year":"2015","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.ejmech.2026.119398_bib9","series-title":"Guidelines for the Treatment of Malaria","year":"2010"},{"key":"10.1016\/j.ejmech.2026.119398_bib10","series-title":"WHO Guidelines for Malaria","year":"2025"},{"key":"10.1016\/j.ejmech.2026.119398_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007483.pub2","article-title":"Artemisinin\u2010based combination therapy for treating uncomplicated malaria","author":"Sinclair","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2026.119398_bib12","article-title":"Artemisinin resistance and malaria elimination: where are we now?","volume":"13","author":"Hanboonkunaparn","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119398_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41579-024-01008-2","article-title":"Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa","volume":"22","author":"Rosenthal","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119398_bib14","doi-asserted-by":"crossref","unstructured":"H. Noedl, Y. Se, K. Schaecher, L. Smith Bryan, D. Socheat, M. Fukuda Mark, Evidence of artemisinin-resistant malaria in Western Cambodia, N. Engl. J. Med., 359 2619-2620. http:\/\/doi.org\/10.1056\/NEJMc0805011.","DOI":"10.1056\/NEJMc0805011"},{"key":"10.1016\/j.ejmech.2026.119398_bib15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119398_bib16","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","article-title":"Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated <em>Plasmodium falciparum<\/em> malaria: a multicentre, open-label, randomised clinical trial","volume":"395","author":"van der Pluijm","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119398_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12936-024-04844-y","article-title":"Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts","volume":"23","author":"Kokori","year":"2024","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2026.119398_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113193","article-title":"Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research","volume":"213","author":"Patel","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib19","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cmi.2025.03.009","article-title":"The non-artemisinin antimalarial drugs under development: a review","volume":"31","author":"Okwu","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2026.119398_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-026-02770-6","article-title":"Advancing global malaria control: therapeutic strategies, drug discovery, and formulation innovations","author":"Sarma","year":"2026","journal-title":"Infection"},{"key":"10.1016\/j.ejmech.2026.119398_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00044-021-02832-4","article-title":"Isatin derivatives as broad-spectrum antiviral agents: the current landscape","volume":"31","author":"Elsaman","year":"2022","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.119398_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/1389557518666180424093305","article-title":"Isatin derivatives and their antiviral properties against arboviruses: a review","volume":"19","author":"De Moraes Gomes","year":"2019","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1021\/acsinfecdis.6b00041","article-title":"Therapeutic potential of spirooxindoles as antiviral agents","volume":"2","author":"Ye","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119398_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107783","article-title":"Molecular hybridization, synthesis, in vitro \u03b1-glucosidase inhibition, in vivo antidiabetic activity and computational studies of isatin based compounds","volume":"153","author":"Patil","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135783","article-title":"Synthesis and biological evaluation of novel isatin-hydrazide conjugates as potential antidiabetic agents","volume":"1288","author":"Alharthy","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119398_bib26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/ph15050536","article-title":"A mini review on Isatin, an anticancer scaffold with potential activities against neglected tropical diseases (NTDs)","volume":"15","author":"Chowdhary","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.119398_bib27","doi-asserted-by":"crossref","first-page":"32188","DOI":"10.1039\/D5RA05002B","article-title":"A comprehensive review and recent advances on isatin-based compounds as a versatile framework for anticancer therapeutics (2020\u20132025)","volume":"15","author":"Alshams","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119398_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113334","article-title":"Structural insights of oxindole based kinase inhibitors as anticancer agents: recent advances","volume":"216","author":"Dhokne","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib29","doi-asserted-by":"crossref","DOI":"10.2174\/0115734064402335250929182136","article-title":"Oxindole analogues as anticancer agents and their therapeutic potential","author":"Pathak","year":"2025","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cclet.2016.07.032","article-title":"Isatin hybrids and their anti-tuberculosis activity","volume":"28","author":"Xu","year":"2017","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119398_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00011-21","article-title":"Biological and biochemical evaluation of isatin-isoniazid hybrids as bactericidal candidates against Mycobacterium tuberculosis","volume":"65","author":"Johansen","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119398_bib32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejmech.2018.12.017","article-title":"Isatin derivatives and their anti-bacterial activities","volume":"164","author":"Guo","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2174\/1573406418666220930145336","article-title":"Isatin conjugates as antibacterial agents: a brief review","volume":"19","author":"Hassan","year":"2023","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib34","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ejmech.2018.06.042","article-title":"Synthesis and antiplasmodial activity of glyco-conjugate hybrids of phenylhydrazono-indolinones and glycosylated 1,2,3-triazolyl-methyl-indoline-2,3-diones","volume":"155","author":"Thakur","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib35","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejmech.2018.11.008","article-title":"Synthesis of isatin based N1-alkylated 3-\u03b2-C-glycoconjugated-oxopropylidene oxindoles as potent antiplasmodial agents","volume":"162","author":"Thakur","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib36","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1016\/j.bmc.2005.02.037","article-title":"Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives","volume":"13","author":"Chiyanzu","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib37","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1039\/D4RA07294D","article-title":"Design and development of an isatin-1, 2, 3-triazole hybrid analogue as a potent anti-inflammatory agent with enhanced efficacy and gene expression modulation","volume":"15","author":"Kumar","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119398_bib38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3390\/antiox11040699","article-title":"Isatin counteracts diethylnitrosamine\/2-acetylaminofluorene-induced hepatocarcinogenesis in male Wistar rats by upregulating anti-inflammatory, antioxidant, and detoxification pathways","volume":"11","author":"Tawfik","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2026.119398_bib39","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1055\/a-2595-6787","article-title":"The isatin scaffold: exceptional potential for the design of potent bioactive molecules","volume":"36","author":"Nazir","year":"2025","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2026.119398_bib40","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s11030-024-10883-z","article-title":"A survey of isatin hybrids and their biological properties","volume":"29","author":"Shu","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2026.119398_bib41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/ph15030272","article-title":"Therapeutic outcomes of isatin and its derivatives against multiple diseases: recent developments in drug discovery","volume":"15","author":"Cheke","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.119398_bib42","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ejmech.2016.08.011","article-title":"Oxindole: a chemical prism carrying plethora of therapeutic benefits","volume":"123","author":"Kaur","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111842","article-title":"Oxindole and its derivatives: a review on recent progress in biological activities","volume":"141","author":"Khetmalis","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.119398_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1871524915666150213122246","article-title":"A mini review on central nervous system potential of isatin derivatives","volume":"15","author":"Phogat","year":"2015","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib45","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/1871524917666171113124112","article-title":"Isatin: new hope against convulsion","volume":"18","author":"Cheke","year":"2018","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib46","doi-asserted-by":"crossref","DOI":"10.2174\/0115680266394265250828164308","article-title":"Isatin derivatives as emerging promising anti-alzheimer agents: focusing on their chemical structure and biological targets","volume":"26","author":"Tamaddon-Abibigloo","year":"2025","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202500743","article-title":"Oxindole derivatives as multi\u2010target agents for Alzheimer's disease: a promising therapeutic strategy","volume":"10","author":"Jhagta","year":"2025","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2026.119398_bib48","doi-asserted-by":"crossref","first-page":"14249","DOI":"10.1039\/D3RA02217J","article-title":"2-Oxindole and related heterocycles: synthetic methodologies for their natural products and related derivatives","volume":"13","author":"Sharma","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119398_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S2468-1253(17)30290-X","article-title":"Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study","volume":"3","author":"Kudo","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2026.119398_bib50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jdermsci.2024.07.004","article-title":"Semaxanib, a VEGF inhibitor, suppresses melanogenesis by modulating CRTC3 independently of VEGF signaling","volume":"115","author":"Kwon","year":"2024","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ejmech.2026.119398_bib51","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.42075","article-title":"Nintedanib in patients with autoimmune disease\u2013related progressive fibrosing interstitial lung diseases: subgroup analysis of the INBUILD trial","volume":"74","author":"Matteson","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ejmech.2026.119398_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408347.2025.2586047","article-title":"Exploring the pharmaceutical significance and analytical landscape of ropinirole: an In-Depth review of an indole-based dopaminergic therapeutic agent","author":"Pawara","year":"2025","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100929","article-title":"Sunitinib resistance in renal cell carcinoma: from molecular mechanisms to predictive biomarkers","volume":"67","author":"Jin","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2026.119398_bib54","doi-asserted-by":"crossref","first-page":"12651","DOI":"10.1016\/0040-4020(96)00737-5","article-title":"Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2\/M phase","volume":"52","author":"Cui","year":"1996","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2026.119398_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101765","article-title":"The early preclinical and clinical development of cipargamin (KAE609), a novel antimalarial compound","volume":"36","author":"Bouwman","year":"2020","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119398_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113400","article-title":"An insight in anti-malarial potential of indole scaffold: a review","volume":"218","author":"Chauhan","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib57","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/molecules27010319","article-title":"Recent progress in the development of indole-based compounds active against malaria, trypanosomiasis and leishmaniasis","volume":"27","author":"Pacheco","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119398_bib58","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/1568026623666230427115241","article-title":"A quinquennial review on recent advancements and developments in search of anti-malarial agents","volume":"23","author":"Dhameliya","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202501989","article-title":"Recent advances in isatin\u2013thiazole hybrids: synthesis, structural design, and biological application","volume":"22","author":"Andrade","year":"2025","journal-title":"Chem. Biodiversity"},{"key":"10.1016\/j.ejmech.2026.119398_bib60","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.2174\/0113895575407443250919042610","article-title":"Synthesis and biological properties of isatin-indole hybrids: a review","volume":"25","author":"Kaur","year":"2025","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400222","article-title":"Unlocking nitrogen compounds' promise against malaria: a comprehensive review","volume":"357","author":"Kuthe","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2026.119398_bib62","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3390\/molecules28020618","article-title":"Spirooxindole: a versatile biologically active heterocyclic scaffold","volume":"28","author":"Panda","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119398_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107091","article-title":"C3-Spirooxindoles: divergent chemical synthesis and bioactivities (2018\u20132023)","volume":"143","author":"Helal","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib64","doi-asserted-by":"crossref","first-page":"22336","DOI":"10.1039\/D5RA03404C","article-title":"Recent advances in the halogenated spirooxindoles as novel anticancer scaffolds: chemistry and bioactivity approach","volume":"15","author":"Nafie","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119398_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101765","article-title":"The early preclinical and clinical development of cipargamin (KAE609), a novel antimalarial compound","volume":"36","author":"Bouwman","year":"2020","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119398_bib66","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1193225","article-title":"Spiroindolones, a potent compound class for the treatment of malaria","volume":"329","author":"Rottmann","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.119398_bib67","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1073\/pnas.0802982105","article-title":"In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen","volume":"105","author":"Plouffe","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A., Early Ed."},{"key":"10.1016\/j.ejmech.2026.119398_bib68","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119398_bib69","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119398_bib70","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature09099","article-title":"Chemical genetics of Plasmodium falciparum","volume":"465","author":"Guiguemde","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119398_bib71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4155\/fmc.15.177","article-title":"Spiroindolone Nitd609 is a novel antimalarial drug that targets the P-type atpase PfATP4","volume":"8","author":"Turner","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib72","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1017\/S0031182013000747","article-title":"Progressing the global antimalarial portfolio: finding drugs which target multiple Plasmodium life stages","volume":"141","author":"Smith","year":"2013","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2026.119398_bib73","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1021\/jm100410f","article-title":"Spirotetrahydro \u03b2-Carbolines (Spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria","volume":"53","author":"Yeung","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib74","doi-asserted-by":"crossref","first-page":"8933","DOI":"10.1021\/acs.jmedchem.5c00614","article-title":"Optimization and characterization of N-Acetamide indoles as antimalarials that target PfATP4","volume":"68","author":"Awalt","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib75","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.chom.2012.12.006","article-title":"Na+ regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials","volume":"13","author":"Spillman","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2026.119398_bib76","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1021\/acsinfecdis.5c00436","article-title":"Identification of \u03b1-Azacyclic acetamide-based inhibitors of P. falciparum Na+ pump (PfATP4) with fast-killing asexual blood-stage antimalarial activity by phenotypic screening","volume":"11","author":"Casas","year":"2025","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119398_bib77","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00087-18","article-title":"Cell swelling induced by the antimalarial KAE609 (cipargamin) and other PfATP4-associated antimalarials","volume":"62","author":"Dennis","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119398_bib78","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/cid\/ciab716","article-title":"Efficacy of cipargamin (KAE609) in a randomized, phase II dose-escalation study in adults in Sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria","volume":"74","author":"Schmitt","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119398_bib79","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01287-23","article-title":"First-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending doses clinical study to assess the safety, tolerability, and pharmacokinetics of cipargamin administered intravenously in healthy adults","volume":"68","author":"Venishetty","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119398_bib80","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.coph.2012.05.001","article-title":"Antiparasitic agents: new drugs on the horizon","volume":"12","author":"M\u00e4ser","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119398_bib81","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1128\/AAC.03393-14","article-title":"A first-in-human randomized, double-blind, placebo-controlled, Single- and multiple-ascending oral dose study of novel antimalarial spiroindolone KAE609 (Cipargamin) to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers","volume":"58","author":"Leong","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119398_bib82","doi-asserted-by":"crossref","first-page":"9092","DOI":"10.1038\/s41467-025-64815-y","article-title":"Endogenous structure of antimalarial target PfATP4 reveals an apicomplexan-specific P-type ATPase modulator","volume":"16","author":"Haile","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119398_bib83","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1128\/AAC.03393-14","article-title":"A first-in-human randomized, double-blind, placebo-controlled, Single- and multiple-ascending oral dose study of novel antimalarial spiroindolone KAE609 (Cipargamin) to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers","volume":"58","author":"Leong","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119398_bib84","article-title":"Defining the antimalarial activity of cipargamin in healthy volunteers experimentally infected with blood-stage Plasmodium falciparum","volume":"65","author":"McCarthy James","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119398_bib85","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s12936-021-04009-1","article-title":"Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in Sub-Saharan Africa","volume":"20","author":"Ndayisaba","year":"2021","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2026.119398_bib86","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa1315860","article-title":"Spiroindolone KAE609 for falciparum and vivax malaria","volume":"371","author":"White","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119398_bib87","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"T. The international natural product sciences, natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119398_bib88","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/metabo2020303","article-title":"A historical overview of natural products in drug discovery","volume":"2","author":"Dias","year":"2012","journal-title":"Metabolites"},{"key":"10.1016\/j.ejmech.2026.119398_bib89","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.lfs.2005.09.012","article-title":"Drug discovery from medicinal plants","volume":"78","author":"Balunas","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2026.119398_bib90","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1021\/acs.jnatprod.5b00883","article-title":"Naturally occurring carbazole alkaloids from Murraya koenigii as potential antidiabetic agents","volume":"79","author":"Patel","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2026.119398_bib91","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.biopha.2017.06.065","article-title":"Anti-colon cancer activity of Murraya koenigii leaves is due to constituent murrayazoline and O-methylmurrayamine A induced mTOR\/AKT downregulation and mitochondrial apoptosis","volume":"93","author":"Arun","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.119398_bib92","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1875692116666180419153313","article-title":"Herbal drug discovery: challenges and perspectives","volume":"16","author":"Parasuraman","year":"2018","journal-title":"Curr. Pharmacogenomics Personalized Med. (CPPM)"},{"key":"10.1016\/j.ejmech.2026.119398_bib93","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1475-2875-10-S1-S4","article-title":"Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions","volume":"10","author":"Rasoanaivo","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2026.119398_bib94","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8749083","article-title":"Alkaloids from plants with antimalarial activity: a review of recent studies","volume":"2020","author":"Uzor","year":"2020","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.ejmech.2026.119398_bib95","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejmech.2019.02.003","article-title":"Pyranocarbazole derivatives as potent anti-cancer agents triggering tubulin polymerization stabilization induced activation of caspase-dependent apoptosis and downregulation of Akt\/mTOR in breast cancer cells","volume":"167","author":"Patel","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib96","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/pca.806","article-title":"HPLC quantification of uncarine D and the anti-plasmodial activity of alkaloids from leaves of Mitragyna inermis (Willd.) O. Kuntze","volume":"16","author":"Fiot","year":"2005","journal-title":"Phytochem. Anal."},{"key":"10.1016\/j.ejmech.2026.119398_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108825","article-title":"Antimalarial spirooxindole alkaloids with a rare 6\/5\/5\/6\/6 polycyclic skeleton from the fungus Penicillium citrinum YSC-1 isolated from a medicinal plant","volume":"164","author":"Wu","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib98","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ddr.21494","article-title":"Design and synthesis of simplified speciophylline analogues and \u03b2-carbolines as active molecules against Plasmodium falciparum","volume":"80","author":"Pierrot","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2026.119398_bib99","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/17460441.2020.1733526","article-title":"An overview of spirooxindole as a promising scaffold for novel drug discovery","volume":"15","author":"Zhou","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119398_bib100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1039\/C4NJ01008F","article-title":"A strategic approach to the synthesis of functionalized spirooxindole pyrrolidine derivatives: in vitro antibacterial, antifungal, antimalarial and antitubercular studies","volume":"39","author":"Haddad","year":"2015","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib101","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/1475-2875-11-387","article-title":"Plasmodium serine hydroxymethyltransferase: indispensability and display of distinct localization","volume":"11","author":"Pornthanakasem","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2026.119398_bib102","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1021\/acs.jmedchem.7b00008","article-title":"Antimalarial inhibitors targeting serine hydroxymethyltransferase (SHMT) with in vivo efficacy and analysis of their binding mode based on X-ray cocrystal structures","volume":"60","author":"Schwertz","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib103","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/cmdc.201800053","article-title":"Potent inhibitors of plasmodial serine hydroxymethyltransferase (SHMT) featuring a spirocyclic scaffold","volume":"13","author":"Schwertz","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119398_bib104","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/cbdd.13598","article-title":"Preparation and antiplasmodial activity of 3', 4'\u2010dihydro\u20101'H\u2010spiro (indoline\u20103, 2'\u2010quinolin)\u20102\u2010ones","volume":"94","author":"Mathebula","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2026.119398_bib105","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.191316","article-title":"3\u2032,4\u2032-Dihydro-2\u2032H-spiro[indoline-3,1\u2032-isoquinolin]-2-ones as potential anti-cancer agents: synthesis and preliminary screening","volume":"7","author":"Lobe","year":"2020","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.ejmech.2026.119398_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74824-0","article-title":"Spirofused tetrahydroisoquinoline-oxindole hybrids as a novel class of fast acting antimalarial agents with multiple modes of action","volume":"10","author":"Efange","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119398_bib107","article-title":"Spirofused tetrahydroisoquinoline-oxindole hybrids (Spiroquindolones) as potential multitarget antimalarial agents: preliminary hit optimization and efficacy evaluation in mice","volume":"66","author":"Efange Noella","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119398_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114324","article-title":"Discovery of spirooxadiazoline oxindoles with dual-stage antimalarial activity","volume":"236","author":"Lopes","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib109","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1021\/acsinfecdis.0c00768","article-title":"Spiro-\u03b2-lactam BSS-730A displays potent activity against HIV and plasmodium","volume":"7","author":"B\u00e1rtolo","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119398_bib110","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1016\/j.tet.2011.09.041","article-title":"Synthesis of mono-, bis-spiro- and dispiro-\u03b2-lactams and evaluation of their antimalarial activities","volume":"67","author":"Jarrahpour","year":"2011","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2026.119398_bib111","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s00044-022-02898-8","article-title":"Synthesis, in-vitro biological evaluation, and molecular docking study of novel spiro-\u03b2-lactam-isatin hybrids","volume":"31","author":"Jarrahpour","year":"2022","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.119398_bib112","doi-asserted-by":"crossref","first-page":"30576","DOI":"10.1039\/D5RA00534E","article-title":"Quinoline derivatives' biological interest for anti-malarial and anti-cancer activities: an overview","volume":"15","author":"Chavan","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119398_bib113","doi-asserted-by":"crossref","first-page":"18594","DOI":"10.1039\/D2RA02896D","article-title":"Recent advances in chemistry and therapeutic potential of functionalized quinoline motifs \u2013 a review","volume":"12","author":"Ajani","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119398_bib114","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.3390\/molecules22122268","article-title":"Quinoline-based hybrid compounds with antimalarial activity","volume":"22","author":"Nqoro","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119398_bib115","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2174\/1871527321666220430144232","article-title":"Design and molecular docking studies of N-Mannich base derivatives of primaquine bearing isatin on the targets involved in the pathophysiology of cerebral malaria","volume":"22","author":"Purohit","year":"2023","journal-title":"CNS Neurol. Disord.-Drug Targets-CNS Neurol. Disord.)"},{"key":"10.1016\/j.ejmech.2026.119398_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138385","article-title":"Design, synthesis and studies on novel N-Mannich base derivatives of isatin targeting dihydrofolate reductase receptor","volume":"1311","author":"Kumar","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119398_bib117","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ejmech.2013.01.032","article-title":"Azide-alkyne cycloaddition en route to 1H-1,2,3-triazole-tethered 7-chloroquinoline-isatin chimeras: synthesis and antimalarial evaluation","volume":"62","author":"Raj","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib118","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1359-6446(03)02933-7","article-title":"The growing impact of click chemistry on drug discovery","volume":"8","author":"Kolb","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.119398_bib119","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/415686a","article-title":"Medical need, scientific opportunity and the drive for antimalarial drugs","volume":"415","author":"Ridley","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119398_bib120","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00228-005-0084-9","article-title":"Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects","volume":"62","author":"R\u00f6shammar","year":"2006","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119398_bib121","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/cbdd.12273","article-title":"7-Chloroquinoline\u2013isatin conjugates: antimalarial, antitubercular, and cytotoxic evaluation","volume":"83","author":"Raj","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2026.119398_bib122","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bmcl.2013.12.109","article-title":"1H-1,2,3-Triazole-tethered isatin-7-chloroquinoline and 3-hydroxy-indole-7-chloroquinoline conjugates: synthesis and antimalarial evaluation","volume":"24","author":"Raj","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119398_bib123","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4269\/ajtmh.1996.55.579","article-title":"Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro","volume":"55","author":"De","year":"1996","journal-title":"Am. J. Trop. Med."},{"key":"10.1016\/j.ejmech.2026.119398_bib124","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ejmech.2014.07.064","article-title":"\u03b2-amino-alcohol tethered 4-aminoquinoline-isatin conjugates: synthesis and antimalarial evaluation","volume":"84","author":"Nisha","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib125","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/cbdd.13738","article-title":"Amalgamating isatin\/indole\/nitroimidazole with 7-chloroquinolines via azide-alkyne cycloaddition: synthesis, anti-plasmodial, and cytotoxic evaluation","volume":"96","author":"Kumar","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2026.119398_bib126","article-title":"Functionalized 3-hydroxy-3-aminoquinoline-oxindole hybrids as promising dual-function anti-plasmodials","volume":"5","author":"Sharma","year":"2022","journal-title":"Eur. J. Med. Chem. Rep"},{"key":"10.1016\/j.ejmech.2026.119398_bib127","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1021\/jm010117d","article-title":"Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysis","volume":"44","author":"Bramson","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib128","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1006\/bbrc.1999.0891","article-title":"Characterization of novel inhibitors of cyclin-dependent kinases","volume":"260","author":"Kent","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2026.119398_bib129","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1021\/jm0300983","article-title":"Oxindole-based compounds are selective inhibitors of Plasmodium falciparum cyclin dependent protein kinases","volume":"46","author":"Woodard","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib130","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ejmech.2011.01.008","article-title":"Design, synthesis and evaluation of 3-methylene-substituted indolinones as antimalarials","volume":"46","author":"Praveen Kumar","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib131","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.2174\/0929867327666200730215316","article-title":"Falcipain-2 and falcipain-3 inhibitors as promising antimalarial agents","volume":"28","author":"Ettari","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib132","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.cclet.2012.05.004","article-title":"Design, synthesis and in vitro evaluation of tetrahydropyrimidine\u2013isatin hybrids as potential antitubercular and antimalarial agents","volume":"23","author":"Akhaja","year":"2012","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119398_bib133","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejps.2004.05.009","article-title":"Drug permeation in biomembranes: in vitro and in silico prediction and influence of physicochemical properties","volume":"23","author":"M\u00e4lki\u00e4","year":"2004","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2026.119398_bib134","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1039\/C8OB01852A","article-title":"Ru-Catalyzed dehydrogenative synthesis of antimalarial arylidene oxindoles","volume":"16","author":"Bisht","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib135","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12936-017-2142-z","article-title":"In vitro anti-malarial interaction and gametocytocidal activity of cryptolepine","volume":"16","author":"Forkuo","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2026.119398_bib136","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1055\/s-0043-104776","article-title":"Chemical composition, antiprotozoal and cytotoxic activities of indole alkaloids and Benzofuran Neolignan of Aristolochia cordigera","volume":"83","author":"Pereira","year":"2017","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2026.119398_bib137","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1475-2875-13-142","article-title":"Anti-malarial activity of indole alkaloids isolated from Aspidosperma olivaceum","volume":"13","author":"Chierrito","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2026.119398_bib138","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1080\/14786419.2021.1895149","article-title":"3-aryl-indolinones derivatives as antiplasmodial agents: synthesis, biological activity and computational analysis","volume":"36","author":"Luczywo","year":"2022","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2026.119398_bib139","article-title":"Synthesis, characterization, biological evaluation, and molecular docking study of novel Isatin incorporated thiazolyl hydrazines","volume":"13","author":"Gore","year":"2024","journal-title":"Lett. Appl. NanoBioSci."},{"key":"10.1016\/j.ejmech.2026.119398_bib140","article-title":"Glycoengineering of interferon-\u03b2 1a improves its biophysical and pharmacokinetic properties","volume":"9","author":"Song","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119398_bib141","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.tet.2016.11.074","article-title":"Synthesis of novel glycosyl-1,2,3-1H-triazolyl methyl quinazolin-4(3H)-ones and their effect on GLUT4 translocation","volume":"73","author":"Ramakrishna","year":"2017","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2026.119398_bib142","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1016\/j.bmcl.2011.08.116","article-title":"Biological evaluation of glycosyl-isoindigo derivatives against the pathogenic agents of tropical diseases (malaria, Chagas disease, leishmaniasis and human African trypanosomiasis)","volume":"21","author":"Bouchikhi","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119398_bib143","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1021\/ic061166p","article-title":"Synthesis, structure, and biological activity of ferrocenyl carbohydrate conjugates","volume":"45","author":"Ferreira","year":"2006","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib144","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1039\/c2dt12050j","article-title":"1,2-Disubstituted ferrocenyl carbohydrate chloroquine conjugates as potential antimalarial agents","volume":"41","author":"Herrmann","year":"2012","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2026.119398_bib145","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1073\/pnas.1330865100","article-title":"Validation of the hexose transporter of Plasmodium falciparum as a novel drug target","volume":"100","author":"Jo\u00ebt","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A., Early Ed."},{"key":"10.1016\/j.ejmech.2026.119398_bib146","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.1021\/jo401210r","article-title":"Rapid Cascade synthesis of poly-heterocyclic architectures from indigo","volume":"78","author":"Shakoori","year":"2013","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib147","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.1016\/j.tet.2015.08.012","article-title":"A cascade synthetic route to new bioactive spiroindolinepyrido [1, 2-a] indolediones from indirubin","volume":"71","author":"Sele","year":"2015","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2026.119398_bib148","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1039\/C8OB00865E","article-title":"Cascade reactions of indigo with oxiranes and aziridines: efficient access to dihydropyrazinodiindoles and spiro-oxazocinodiindoles","volume":"16","author":"Butler","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib149","doi-asserted-by":"crossref","first-page":"27769","DOI":"10.1021\/acsomega.2c01779","article-title":"Synthesis of chalcones derivatives and their biological activities: a review","volume":"7","author":"Elkanzi","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.119398_bib150","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.bmcl.2010.02.017","article-title":"Comparison of the antiplasmodial and falcipain-2 inhibitory activity of \u03b2-amino alcohol thiolactone-chalcone and isatin-chalcone hybrids","volume":"20","author":"Hans","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119398_bib151","doi-asserted-by":"crossref","first-page":"12352","DOI":"10.1073\/pnas.95.21.12352","article-title":"Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum","volume":"95","author":"Waller","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A., Early Ed."},{"key":"10.1016\/j.ejmech.2026.119398_bib152","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.bmcl.2011.02.008","article-title":"Novel thiolactone\u2013isatin hybrids as potential antimalarial and antitubercular agents","volume":"21","author":"Hans","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119398_bib153","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1021\/cr0101510","article-title":"Bioorganometallic chemistry of ferrocene","volume":"104","author":"Van Staveren","year":"2004","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.119398_bib154","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2875-5-11","article-title":"Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure","volume":"5","author":"Daher","year":"2006","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2026.119398_bib155","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.3390\/molecules13112900","article-title":"Ferroquine, an ingenious antimalarial drug \u2013Thoughts on the mechanism of action","volume":"13","author":"Dubar","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119398_bib156","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ejmech.2014.10.024","article-title":"1H-1,2,3-triazole tethered isatin-ferrocene conjugates: synthesis and in vitro antimalarial evaluation","volume":"87","author":"Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119398_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2025.108910","article-title":"Study of antiplasmodial activity, toxicity, pharmacokinetic profiles of n-methyl-isatin (CH3ISACN) derivative","volume":"270","author":"Melo","year":"2025","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2026.119398_bib158","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.pt.2020.04.002","article-title":"A way forward for culturing Plasmodium vivax","volume":"36","author":"Gunalan","year":"2020","journal-title":"Trends Parasitol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:55:35Z","timestamp":1793966135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426008433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":158,"alternative-id":["S0223523426008433"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119398","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimalarial efficacy of isatin and oxindole derivatives: A comprehensive update","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119398"}}